ReviewFrontiers in immunology2026
Integrating
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The traditional paradigm of linking single genes to individual phenotypes is being replaced by a systems-level framework to understand the complexity of the tumor microenvironment. In this context, in silico knockout has emerged as a powerful computational approach to predict system-wide responses to genetic or cellular perturbations. This review summarizes how multilayer regulatory information across the genome, transcriptome, proteome, and metabolome can be integrated into computational models for virtual perturbation analysis. We outline major multi-omics data sources, including bulk, single-cell, and spatial omics, and emphasize how these data are transformed into model-compatible inputs such as constraint-based matrices and latent embeddings. We then discuss the evolution of in silico knockout methodologies, from genome-scale metabolic models and flux balance analysis to advanced deep learning frameworks that enable the prediction of non-linear and unseen perturbations. The integration of spatial transcriptomics further extends these approaches to tissue-level modeling of cell-cell interactions. In tumor immunology, these methods facilitate the identification of immune regulatory genes, the analysis of immune evasion mechanisms, and the prioritization of therapeutic targets. Despite current challenges in multi-omics integration and biological complexity, in silico knockout provides a promising framework for advancing precision immunotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.